ストックスクリーナーアプリを入手
7.78
0.78%
0.06
アフターアワーズ：
7.66
-0.12
-1.54%
Anavex Life Sciences Corporation (AVXL) 最新ニュース
Cetera Investment Advisers Acquires New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Bank of America Corp DE Sells 76,485 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Ameriprise Financial Inc. Buys 3,243 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Millennium Management LLC Sells 133,208 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Lessened by BNP Paribas Financial Markets - Defense World
Deutsche Bank AG Has $693,000 Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. E. Shaw & Co. Inc. Purchases Shares of 105,130 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Northern Trust Corp Raises Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
The Manufacturers Life Insurance Company Has $298,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
HC Wainwright Issues Positive Forecast for AVXL Earnings - Defense World
Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37% - Yahoo Finance
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Tower Research Capital LLC TRC Buys 1,708 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlight - GuruFocus
Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo Finance
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call Transcript - Insider Monkey
Anavex Life Sciences to Participate at Upcoming Healthcare Confe - GuruFocus
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences | AVXL Stock News - GuruFocus
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - The Manila Times
Anavex Brings Alzheimer's and Parkinson's Drug Updates to Prestigious Wainwright Healthcare Conferences - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - CT Insider
Anavex Life Sciences Reports Q2 2025 Financial Results - TipRanks
Raymond James Financial Inc. Makes New $167,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Earnings call transcript: Anavex Life Sciences Q2 2025 reports net loss, stock rises - Investing.com Nigeria
Anavex Life Sciences (AVXL) Q2 Earnings Exceed Expectations - GuruFocus
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financia - GuruFocus
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update - The Manila Times
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update | AVXL Stock News - GuruFocus
Anavex Life Sciences Corp. Reports Q2 Fiscal 2025 Financial Results and Updates on Clinical Developments - Nasdaq
Anavex Life Sciences Corp. Q2 Loss Beats Estimates - Nasdaq
Anavex Life Sciences Corp expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Is Anavex Life Sciences Corp. (AVXL) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Closing Bell Recap: Anavex Life Sciences Corporation (AVXL) Ends at 8.91, Reflecting a -4.81 Downturn - DWinneX
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Fina - GuruFocus
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 | AVXL Stock News - GuruFocus
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 - The Manila Times
Anavex Life Sciences Corp. to Announce Second Fiscal Quarter Financial Results on May 13, 2025 - Nasdaq
Anavex Life Sciences Earnings Preview: Key Updates Coming on Alzheimer's and Rare Disease Programs - Stock Titan
Envestnet Asset Management Inc. Purchases 20,771 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Envestnet Asset Management Inc. Lowers Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Head-To-Head Comparison: Anavex Life Sciences (NASDAQ:AVXL) vs. Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World
Taking on analysts’ expectations and winning: Anavex Life Sciences Corporation (AVXL) - Sete News
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by JPMorgan Chase & Co. - Defense World
Anavex Life Sciences' Schizophrenia Clinical Study Completes Enrollment - marketscreener.com
Anavex Life Sciences Corporation (AVXL) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - The Manila Times
Anavex Life Sciences Corporation [AVXL] Records 50-Day SMA of $8.86 - knoxdaily.com
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference | AVXL Stock News - GuruFocus
0.86%
1.24%
大文字化:
|
ボリューム (24 時間):